Frequent loss of pRb2/p130 in human ovarian carcinomaD'ANDRILLI, Giuseppina; MASCIULLO, Valeria; SCAMBIA, Giovanni et al.Clinical cancer research. 2004, Vol 10, Num 9, pp 3098-3103, issn 1078-0432, 6 p.Article

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinomaBENENCIA, Fabian; COURREGES, Maria C; CONEJO-GARCUIA, José R et al.Human gene therapy. 2005, Vol 16, Num 6, pp 765-778, issn 1043-0342, 14 p.Article

Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancerPOPADIUK, Cathy M; JIEYING XIONG; WELLS, Malcolm G et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2216-2223, issn 1078-0432, 8 p., 1Article

Meningeal metastases from ovarian carcinomaMUKHOPADHYAY, Surabhi; MUKHOPADHYAY, Sanjay; EL-ZAMMAR, Ola et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 1010-1011, issn 0732-183X, 2 p.Article

Hormonal therapy in epithelial ovarian cancerRAO, Gautam G; MILLER, David Scott.Expert review of anticancer therapy. 2006, Vol 6, Num 1, pp 43-47, issn 1473-7140, 5 p.Article

The IgLON family in epithelial ovarian cancer : Expression profiles and clinicopathologic correlatesNTOUGKOS, Evangelos; RUSH, Robert; SCOTT, Diane et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5764-5768, issn 1078-0432, 5 p.Article

Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patientsGORDON, Ilyssa O; FREEDMAN, Ralph S.Clinical cancer research. 2006, Vol 12, Num 5, pp 1515-1524, issn 1078-0432, 10 p.Article

Different expression levels of α3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell linesESCREVENTE, C; MACHADO, E; BRITO, C et al.International journal of oncology. 2006, Vol 29, Num 3, pp 557-566, issn 1019-6439, 10 p.Article

Glucocorticosteroid receptors in ovarian carcinomasWOENCKHAUS, Joachim; FRANKE, Folker E; HACKETHAL, Andreas et al.Oncology reports. 2006, Vol 15, Num 5, pp 1137-1140, issn 1021-335X, 4 p.Article

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinomaHAN, Liz Y; LANDEN, Charles N; KAMAT, Aparna A et al.Journal of clinical oncology. 2006, Vol 24, Num 5, pp 755-761, issn 0732-183X, 7 p.Article

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumorsDENKERT, Carsten; BUDCZIES, Jan; KIND, Tobias et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10795-10804, issn 0008-5472, 10 p.Article

Detection of epithelial ovarian cancer using ¹H-NMR-based metabonomicsODUNSI, Kunle; WOLLMAN, Robert M; FENG QIAN et al.International journal of cancer. 2005, Vol 113, Num 5, pp 782-788, issn 0020-7136, 7 p.Article

Growth inhibitory effect of D-allose on human ovarian carcinoma cells In VitroLI SUI; YOUYI DONG; WATANABE, Yasuo et al.Anticancer research. 2005, Vol 25, Num 4, pp 2639-2644, issn 0250-7005, 6 p.Article

Loss of Gelsolin expression in human ovarian carcinomasNOSKE, Aurelia; DENKERT, Carsten; SCHOBER, Hagen et al.European journal of cancer (1990). 2005, Vol 41, Num 3, pp 461-469, issn 0959-8049, 9 p.Article

Plasmacytoid dendritic cells induce CD8⁺ regulatory T cells in human ovarian carcinomaSHUANG WEI; KRYCZEK, Ilona; LINHUA ZOU et al.Cancer research (Baltimore). 2005, Vol 65, Num 12, pp 5020-5026, issn 0008-5472, 7 p.Article

Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomasUEDA, Masatsugu; HUNG, Yao-Ching; TERAI, Yoshito et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3225-3232, issn 1078-0432, 8 p.Article

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclearGOURLEY, C; PAIGE, A. J. W; TAYLOR, K. J et al.International journal of oncology. 2005, Vol 26, Num 6, pp 1681-1689, issn 1019-6439, 9 p.Article

Androgen mediation of thrombocytosis in epithelial ovarian cancer biologyLI, Andrew John; YOUNG KARLAN, Beth.Clinical cancer research. 2005, Vol 11, Num 22, pp 8015-8018, issn 1078-0432, 4 p.Article

Recurrent epithelial ovarian cancer : Validation and improvement of an established prognostic indexGRONLUND, Bo; CHRISTENSEN, Ib J; BÜLOW-LEHNSBY, Anne Lene et al.European journal of obstetrics, gynecology, and reproductive biology. 2005, Vol 123, Num 1, pp 98-106, issn 0301-2115, 9 p.Article

Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer : A single institution experienceBOZAS, George; DIMOPOULOS, Meletios A; PAPADIMITRIOU, Christos et al.Oncology. 2006, Vol 70, Num 4, pp 265-272, issn 0030-2414, 8 p.Article

Le cancer de l'ovaire rémanent : À propos d'une observation = Retained ovarian remnant carcinoma : a case reportLE BOUËDEC, G; BAILLY, C; DE LAPASSE, C et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2006, Vol 35, Num 8, pp 829-833, issn 0368-2315, 5 p., CAH1Article

Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cellsGUTWEIN, Paul; STOECK, Alexander; ALTEVOGT, Peter et al.Clinical cancer research. 2005, Vol 11, Num 7, pp 2492-2501, issn 1078-0432, 10 p.Article

Hereditary ovarian cancerPRAT, Jaime; RIBE, Adriana; GALLARDO, Alberto et al.Human pathology. 2005, Vol 36, Num 8, pp 861-870, issn 0046-8177, 10 p.Article

Histologic type, organ of origin, and wnt pathway status: Effect on gene expression in ovarian and uterine carcinomasSHEDDEN, Kerby A; KSHIRSAGAR, Malti P; CHO, Kathleen R et al.Clinical cancer research. 2005, Vol 11, Num 6, pp 2123-2131, issn 1078-0432, 9 p.Article

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potentialMEINHOLD-HEERLEIN, Ivo; BAUERSCHLAG, Dirk; SEHOULI, Jalid et al.Oncogene (Basingstoke). 2005, Vol 24, Num 6, pp 1053-1065, issn 0950-9232, 13 p.Article